HMGA1 and neoplasm: First, we developed a comprehensive computational framework to simultaneously analyze: (i) the genetic and epigenetic determinants of HMGA1 dysregulation; (ii) its impact on tumor immunity and patient prognosis; and (iii) its potential as a predictive biomarker for therapy response.